Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Energy Transfer LP Unit

Intel

ONEOK

Rio Tinto plc Sponsored

Simon Property Group

Verizon

While it is becoming clear that inflation is dropping, November's consumer price index came in up 7.1% year over year (versus expectations for 7.3%), the reality is that costs for essential items like food remain very high.

Sell the Rally Now and Grab These 7 ‘Strong Buy' 5% and Higher 2023 Dividend Winners

Apple

Bank of America

Blackrock Inc

Microsoft

NIKE

Realty Income Corp

Unilever

Visa

Exxon Mobil

Imagine that you will invest $10,000 and you aim to combine Dividend Income with Dividend Growth. I will demonstrate how you could reach a balanced mix between Dividend Income and Dividend Growth when building an investment portfolio.

How To Allocate $10,000 Among 10 Dividend Income And Dividend Growth Stocks

Kraft Heinz

Are these the top dividend stocks to watch in the stock market today?

3 Dividend Stocks To Watch In The Stock Market Today

Clorox

Gap Inc

Hanesbrands

Macerich

Scotts Miracle-Gro

ZIM Integrated Shipping Services

The economy is either already in recession or it is likely to be in one in 2023. As a result, some dividend stocks are worth buying for investors.

7 Dividend Stocks to Sell Before They Dive in 2023

Chevron

Kimberly-Clark

McDonald's

Procter & Gamble

Public Storage

V.F.

The top dividend stock picks for 2023 are surefire ways for investors to protect themselves against several current issues. Their dividends provide extra returns for portfolios that have been battered in a very difficult 2022.

Our 7 Top Dividend Stock Picks for 2023

Dollar General

Altria and Dollar General could be great buys in this uncertain economic climate.

Got $1,000? 2 Value Stocks to Buy Right Now

Juul Labs Inc. has agreed to pay $1.7 billion in a broad legal settlement covering more than 5,000 lawsuits, according to people familiar with the matter.

Juul to pay $1.7 billion in legal settlement involving more than 5,000 lawsuits

The settlement announced earlier this week covers more than 5,000 lawsuits and involves allegations the e-cigarette maker marketed to children and teens.

Juul to Pay $1.7 Billion in Legal Settlement

Juul Labs gets equity investment to pay $1.2 billion in settlements for contributing to America's youth vaping epidemic.

Juul Labs will pay $1.2B for role in youth-vaping epidemic

The e-cigarette maker previously agreed to pay $438.5 million to settle a lawsuit claiming the company had marketed its products to teenagers.

Juul To Pay $1.2 Billion To Settle Youth-Vaping Lawsuits

The settlement comes a month after the once red-hot vaping company had secured an investment from some of its early investors that would help Juul stay in business.

Juul to settle 10,000 youth-vaping lawsuits — here's what it will cost e-cig maker

Philip Morris

In this comparative analysis, I will analyze which of the two tobacco product manufacturers - Altria Vs. Philip Morris- I consider to be the more attractive dividend income stock. At this moment, Altria shows a higher Dividend Yield (7.97% as compared to 4.91% of Philip Morris) and a slightly lower Payout Ratio (76.63% compared to 84.80%).

Altria Vs. Philip Morris: Which Is The More Attractive Dividend Income Stock?

Cheaper cigarette brands are taking market share from large rivals such as BAT and Altria as smokers look for ways to save cash.

Bargain-Hunting Smokers Give Big Tobacco a Headache

The company has narrowly avoided bankruptcy and agreed to pay $439 million to US states and territories in a separate settlement in September.

Juul settles another 5,000 lawsuits after receiving equity investment, an effort CEO calls 'yet another significant step to secure our path forward'

Manager Directed Portfolios - iM DBi Managed Futures Strategy ETF

Vanguard Extended Duration Treasury ETF

Enterprise Products Partners

Legal & General Group PLC

Magellan Midstream Partners

MPLX

Schwab US Dividend Equity ETF

The 60/40 used to yield 10%, and today yields just 2%. In the future, 7.2% returns are expected from the gold standard retirement portfolio. You can build an ultra-low volatility ultra-yield retirement portfolio using just eight high-yield blue-chips.

8 High-Yield Blue Chips That Yield 3X Your 60/40 Retirement Portfolio

Hershey

PepsiCo

Walmart

These stocks can pad your pockets and pay your bills.

5 Passive Income Stocks That Can Help Make You Richer

Coterra Energy

Medical Properties Trust

Vornado Realty Trust

In a big reversal over the past month, longer-dated Treasury securities yields have tumbled back to levels not seen since early September.

7 Surprising Analyst Favorite Buy-Rated Stocks Pay Huge and Growing Dividends

Altria is trading down around 16% from its 2022 highs, but if you go back a few years the decline is 38%.

Altria Is Down 38% From Its High. Time to Buy?

AGNC Investment

Historically high inflation is no match for these rock-solid income stocks with yields ranging from 7.7% to 14.4%.

3 Ultra-High-Yield Dividend Stocks That Can Help You Crush Inflation in 2023

e-cigarette firm Juul Labs is said to be using an equity raise to the cover the costs of newly agreed legal settlements. The company has reached a settlement with over 5,000 lawsuits and 10,000 individual plaintiffs, that's according to reports citing an internal company memo sent to staff by Juul chief executive K.C.

Juul Labs taps equity as it agrees to settle with 10,000 plaintiffs

Stitch Fix

Toll Brothers

The e-cigarette industry will be watching reaction to JUUL settling thousands of lawsuits, along with reaction to Toll Brothers earnings.

JUUL settles, Toll Brothers results, Stitch Fix loss and more: Wednesday's 5 things to know

JUUL on Tuesday announced it has settled over 5,000 lawsuits with roughly 10,000 individual plaintiffs against the e-cigarette maker.

Juul settles over 5,000 vaping lawsuits, settlement not disclosed

The deal resolves much of legal uncertainty around the e-cigarette company, which was accused of marketing to children and teens.

Juul Reaches Settlement of Over 5,000 Lawsuits

Juul Labs Inc. reached a sweeping legal settlement Tuesday covering more than 5,000 lawsuits and about 10,000 individual plaintiffs. Financial terms weren't disclosed.

Juul reaches sweeping settlement involving more than 5,000 lawsuits

W.W. Grainger

The 48 Dividend Kings finished November with a nice gain, collectively up 6.60%. Last month, the 11 best dividend kings based on forecasted growth and valuation underperformed the average dividend king return by 217 bps.

My 11 Best Dividend Kings For December 2022

News for Altria Stock (MO)